Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.870
-0.150 (-3.73%)
Aug 27, 2026, 4:08 PM HKT

HKG:2591 Statistics

Total Valuation

HKG:2591 has a market cap or net worth of HKD 1.84 billion. The enterprise value is 830.13 million.

Market Cap1.84B
Enterprise Value 830.13M

Important Dates

The next estimated earnings date is Friday, August 28, 2026.

Earnings Date Aug 28, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2591 has 456.82 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class 420.29M
Shares Outstanding 456.82M
Shares Change (YoY) +3.44%
Shares Change (QoQ) +6.58%
Owned by Insiders (%) 10.12%
Owned by Institutions (%) 47.43%
Float 254.49M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.38
PB Ratio 1.69
P/TBV Ratio 1.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.69
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.16.

Current Ratio 3.50
Quick Ratio 3.14
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF -0.42
Interest Coverage -93.42

Financial Efficiency

Return on equity (ROE) is -41.16% and return on invested capital (ROIC) is -24.61%.

Return on Equity (ROE) -41.16%
Return on Assets (ROA) -20.15%
Return on Invested Capital (ROIC) -24.61%
Return on Capital Employed (ROCE) -37.81%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.14
Inventory Turnover 0.40

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.34% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -92.34%
50-Day Moving Average 7.03
200-Day Moving Average 20.31
Relative Strength Index (RSI) 19.51
Average Volume (20 Days) 7,071,851

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2591 had revenue of HKD 176.96 million and -386.00 million in losses. Loss per share was -0.85.

Revenue176.96M
Gross Profit 142.28M
Operating Income -416.53M
Pretax Income -386.00M
Net Income -386.00M
EBITDA -406.99M
EBIT -416.53M
Loss Per Share -0.85
Full Income Statement

Balance Sheet

The company has 1.18 billion in cash and 174.58 million in debt, with a net cash position of 1.01 billion or 2.20 per share.

Cash & Cash Equivalents 1.18B
Total Debt 174.58M
Net Cash 1.01B
Net Cash Per Share 2.20
Equity (Book Value) 1.09B
Book Value Per Share 2.38
Working Capital 995.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -397.19 million and capital expenditures -21.25 million, giving a free cash flow of -418.44 million.

Operating Cash Flow -397.19M
Capital Expenditures -21.25M
Depreciation & Amortization 8.35M
Net Borrowing 161.45M
Free Cash Flow -418.44M
FCF Per Share -0.92
Full Cash Flow Statement

Margins

Gross margin is 80.40%, with operating and profit margins of -235.38% and -218.13%.

Gross Margin 80.40%
Operating Margin -235.38%
Pretax Margin -218.13%
Profit Margin -218.13%
EBITDA Margin -229.99%
EBIT Margin -235.38%
FCF Margin n/a

Dividends & Yields

HKG:2591 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.44%
Shareholder Yield -3.44%
Earnings Yield -21.02%
FCF Yield -22.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Analyst Forecast

The average price target for HKG:2591 is 31.68, which is 718.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target 31.68
Price Target Difference 718.61%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 149.07%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a